Evaluating the efficacy of allopurinol for the treatment of cutaneous leishmaniasis

Int J Dermatol. 1997 Dec;36(12):938-40. doi: 10.1046/j.1365-4362.1997.00308.x.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Allopurinol / adverse effects
  • Allopurinol / therapeutic use*
  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Brazil / epidemiology
  • Child
  • Evaluation Studies as Topic
  • Follow-Up Studies
  • Humans
  • Leishmaniasis, Cutaneous / drug therapy*
  • Leishmaniasis, Cutaneous / epidemiology
  • Meglumine / therapeutic use
  • Middle Aged
  • Mucous Membrane / pathology
  • Treatment Outcome
  • Ulcer / chemically induced
  • Uric Acid / blood

Substances

  • Antimetabolites, Antineoplastic
  • Uric Acid
  • Allopurinol
  • Meglumine